Félix Couture
机构：Hôtel-Dieu de Québec, Université Laval · ORCID：0009-0002-0190-1938
发表论文 188 篇 · 总被引 5649 次 · h-index 36
代表论文
- Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (2024 · Annals of Oncology · 被引 347)
- Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study (2024 · Journal of Clinical Oncology · 被引 92)
- Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance) (2024 · Journal of Clinical Oncology · 被引 30)
- Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702. (2025 · Journal of Clinical Oncology · 被引 10)
- Association between empirical dietary inflammatory pattern (EDIP) and survival in patients with stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance). (2025 · Journal of Clinical Oncology · 被引 4)
- Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 4)